about
Tea consumption and incidence of type 2 diabetes in Europe: the EPIC-InterAct case-cohort studyHematopoietic toxicity and cell cycle perturbations induced by new DNA minor groove-alkylating agents.Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition.Oral contraceptives, reproductive history and risk of colorectal cancer in the European Prospective Investigation into Cancer and NutritionClassic Kaposi's sarcoma in Italy, 1985-1998Pattern of cancer risk in persons with AIDS in Italy in the HAART era.Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects.Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: a cohort study.Consistency and accuracy of diagnostic cancer codes generated by automated registration: comparison with manual registration.Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC CohortConcentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.Descriptive epidemiology of selected birth defects, areas of Lombardy, Italy, 1999.L1210 cells selected for resistance to methoxymorpholinyl doxorubicin appear specifically resistant to this class of morpholinyl derivativesAnthropometry and the Risk of Lung Cancer in EPICColorectal cancer survival in the USA and Europe: a CONCORD high-resolution study.Atmospheric fine particulate matter and breast cancer mortality: a population-based cohort study.Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution study.Estimated and observed cancer incidence in Italy: a validation study.Out-of-pocket costs for cancer survivors between 5 and 10 years from diagnosis: an Italian population-based study.Prediagnostic telomere length and risk of B-cell lymphoma-Results from the EPIC cohort study.Smoking and lymphoma risk in the European prospective investigation into cancer and nutrition.Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study.Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition.Plasma Riboflavin and Vitamin B-6, but Not Homocysteine, Folate, or Vitamin B-12, Are Inversely Associated with Breast Cancer Risk in the European Prospective Investigation into Cancer and Nutrition-Varese Cohort.Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case-Control Study in Nonsmoking Postmenopausal Women from the EPIC Cohort.Flavone acetic acid antitumour activity against a mouse pancreatic adenocarcinoma is mediated by natural killer cells.Intracellular glutathione heterogeneity in L1210 murine leukemia sublines made resistant to DNA-interacting anti-neoplastic agents.Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studies.Changes in the incidence of thyroid cancer between 1991 and 2005 in Italy: a geographical analysis.Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study.Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort.Comparison with manual registration reveals satisfactory completeness and efficiency of a computerized cancer registration system.Survival after cancer in Italian persons with AIDS, 1986-2005: a population-based estimation.Alcohol drinking and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.The role of histological investigation in prognostic evaluation of advanced gastric cancer. Analysis of histological structure and molecular changes compared with invasive pattern and stage.Anthropometric characteristics and risk of lymphoid and myeloid leukemia in the European Prospective Investigation into Cancer and Nutrition (EPIC).A method to estimate mortality trends when death certificates are imprecisely coded: an application to cervical cancer in Italy.Antitumor activity of 1,4-bis (2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane dimaleate (Dabis Maleate) in M5076 and its subline resistant to cyclophosphamide M5/CTX.Coding criteria of bladder cancer: effects on estimating survival.[Methodological issues and first results of a record linkage between AIDS and Cancer Registries in Italy]
P50
Q28729072-BD386D32-B4CA-4775-A3EF-3FCA0501C322Q33500406-F1248275-1B8A-4B32-B781-BB7412AD099EQ34010805-0B4F23CE-A416-45C0-9E47-C94080566706Q34363520-7C3DFB65-A28A-4BD1-B021-3115F9A9648DQ34552954-63419EF9-5082-4615-A6A8-BC569A8C83DCQ34604639-33B3A184-4ACD-4731-A26D-30AFEFB97D7FQ34624429-A4A8C1C0-6890-47AA-B885-CBB0386111B3Q34660089-783592C0-7D3A-4156-B257-D889C72AAF3EQ35069362-B6F9412A-7886-4565-B804-BCC58DA3A640Q35680361-9B787209-C449-4D05-9C5A-47ADA0FC021BQ35835118-E5078D30-B8C8-4088-A3E6-1E9CD86EC159Q35846818-490137C3-2250-420D-900B-7B6435214394Q35977659-B5BAF8CF-93FD-4BBE-BDE6-E5286BAA369EQ37096164-82164E54-BBA9-450B-BAD8-5B570CE6C3DFQ37172593-225C907E-83E5-438A-8142-6D52BC5CC30AQ37455153-41F604B4-CA97-4EAB-85A7-B1D59B921242Q38417399-FCA98D57-9A2B-4DD1-9705-AA370E14F0B4Q38460374-3002E7AA-716B-4985-9042-3B96DF84623EQ38942318-C67E5F46-3CCD-47E7-BBC9-A3AB006CEAD8Q39202709-6BBEAD11-E462-4A95-90C4-FCC25E5DF320Q40116485-CE5933C3-B602-4DFC-9D3E-AB881CE80B87Q40186128-5ED1FD65-AD9C-48AA-876B-527FFEA00AF3Q40327404-C3CC4675-A58C-4709-8A34-C83EF46EC0F2Q40778854-9994BF98-B6FA-420C-9FFF-5E1065D23970Q41103200-37B444EF-364B-4B01-B84F-47570DF91132Q41215380-33096CFF-C8C1-4BBA-B7DA-B6AA5BE213F0Q41552635-22B23BE9-D726-4AFF-8436-08C90EC43E5FQ41578144-BB3C80FD-7C76-4A56-903E-5F98AACE4004Q41978080-73CA3528-DE30-438D-926B-21BBD1CBD64BQ42230477-7D584184-177C-4BB0-87A4-ADB06ABC311BQ42371001-EA4932C3-75C7-4D84-B656-D43B3C523966Q42617982-AFC8778D-4665-418F-AE1C-71FE2CA70D79Q43561645-204FA4C5-6469-412D-BD6B-337A684D5F50Q43658789-E724558E-7DE7-4EA7-A216-DC77AB28FCC9Q43740838-48E4680F-90BD-4054-A902-7BE70EBC3416Q43786700-9CCD2D2C-D521-483B-96E3-DCFEE94D4EB2Q43825764-512C051C-0E67-481E-874E-D9FEDCC1189CQ43945783-9FFD6AA0-15DD-42F6-BDD9-E00AB180E268Q44010790-BF154895-4642-4AA4-886D-25A1E943C1BCQ44671692-CC1D34CB-158A-4EA8-8B20-425572F0BA04
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giovanna Tagliabue
@ast
Giovanna Tagliabue
@en
Giovanna Tagliabue
@es
Giovanna Tagliabue
@nl
Giovanna Tagliabue
@sl
type
label
Giovanna Tagliabue
@ast
Giovanna Tagliabue
@en
Giovanna Tagliabue
@es
Giovanna Tagliabue
@nl
Giovanna Tagliabue
@sl
prefLabel
Giovanna Tagliabue
@ast
Giovanna Tagliabue
@en
Giovanna Tagliabue
@es
Giovanna Tagliabue
@nl
Giovanna Tagliabue
@sl
P1053
D-4194-2017
P106
P1153
7003588000
P21
P31
P3829
P496
0000-0001-8165-5524